← Back to Patent Explorer
US4096237A Expired / Lapsed US ⏱️ 0.0 years remaining

Immunoassay for β-endorphin

Assignee: University of California Berkeley
•
Filing: 1977-03-14
•
Granted: 1978-06-20
•
Expires: 1997-03-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A sensitive radioimmunoassay for β-endorphin (β-EP) is disclosed. It appears that the antigenic determinant resides in residues 6-15 of this molecule.

Inventors

  • 👤 Choh Hao Li

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 15:43
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/94; G01N33/9486; C; C07; C07K; C07K14/00; C07K14/435; C07K14/665; C07K14/675; C07K16/00; C07K16/18; C07K16/26; Y; Y10; Y10S; Y10S436/00; Y10S436/804; Y10S436/815; Y10S436/823

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 11 words
An antigen comprising β-endorphin covalently bound to an immunogenic carrier material.
Claim 2
Dependent Claim 11 words
An antigen comprising β-endorphin covalently bound to an immunogenic carrier material.
Claim 3
Dependent Claim 14 words
The antigen of claim 1 where said β-endorphin is human β-endorphin (β h -endorphin).
Claim 4
Dependent Claim 14 words
The antigen of claim 1 wherein said β-endorphin is canoel β-endorphin (β c -endorphin).
Claim 5
Dependent Claim 14 words
The antigen of claim 1 wherein said immogenic carrier material is human gamma globulin.
Claim 6
Dependent Claim 2 words
125 I-β-endorphin.
Claim 7
Dependent Claim 2 words
125 I-β-endorphin.
Claim 8
Dependent Claim 11 words
The compound of claim 5 which is 125 I-β h -endorphin.
Claim 9
Dependent Claim 17 words
An antibody having the property of specifically binding β-endorphin or fragments thereof containing the (6-15) residue sequence.
Claim 10
Dependent Claim 17 words
An antibody having the property of specifically binding β-endorphin or fragments thereof containing the (6-15) residue sequence.
Claim 11
Dependent Claim 98 words
A radioimmunoassay for β-endorphin or a fragment thereof containing the (6-15) residue sequence which assay comprises incubating a mixture comprising the test sample containing an unknown amount of said β-endorphin or a fragment thereof containing the (6-15) residue sequence, a radiolabelled β-endorphin tracer compound and an antibody having the property of specifically binding β-endorphin or fragments thereof containing the (6-15) residue sequence; separating the free and the bound β-endorphin; counting the radioactivity from either the free or bound β-endorphin and determining the concentration of β-endorphin or fragment thereof in the test sample by reference to a standard curve.
Claim 12
Dependent Claim 98 words
A radioimmunoassay for β-endorphin or a fragment thereof containing the (6-15) residue sequence which assay comprises incubating a mixture comprising the test sample containing an unknown amount of said β-endorphin or a fragment thereof containing the (6-15) residue sequence, a radiolabelled β-endorphin tracer compound and an antibody having the property of specifically binding β-endorphin or fragments thereof containing the (6-15) residue sequence; separating the free and the bound β-endorphin; counting the radioactivity from either the free or bound β-endorphin and determining the concentration of β-endorphin or fragment thereof in the test sample by reference to a standard curve.
Claim 13
Dependent Claim 16 words
The assay of claim 8 wherein said radiolabelled β-endorphin tracer compound is 125 I-β h -endorphin.
Claim 14
Dependent Claim 20 words
The assay of claim 8 wherein said incubation is carried out at 4° C. for about 16 to 20 hours.
Claim 15
Dependent Claim 13 words
The assay of claim 8 wherein said test sample comprises β h -endorphin.
Claim 16
Dependent Claim 133 words
An immunoassay for β-endorphin or fragments thereof containing the (6-15) residue sequence which assay comprises incubating a mixture comprising the test sample containing an unknown amount of said β-endorphin or fragments thereof containing the (6-15) residue sequence, labeled β-endorphin or fragments thereof containing the (6-15) residue sequence and an antibody having the property of specifically binding β-endorphin or fragments thereof containing the (6-15) residue sequence, separating the free and the bound β-endorphin or fragments thereof containing the (6-15) residue sequence; measuring the amount of labeled β-endorphin or fragments thereof containing the (6-15) reside sequence from either the free or bound β-endorphin or fragments thereof containing the (6-15) residue sequence and determining the concentration of β-endorphin of fragments thereof containing the (6-15) residue sequence in the test sample by reference to a standard curve.
Claim 17
Dependent Claim 133 words
An immunoassay for β-endorphin or fragments thereof containing the (6-15) residue sequence which assay comprises incubating a mixture comprising the test sample containing an unknown amount of said β-endorphin or fragments thereof containing the (6-15) residue sequence, labeled β-endorphin or fragments thereof containing the (6-15) residue sequence and an antibody having the property of specifically binding β-endorphin or fragments thereof containing the (6-15) residue sequence, separating the free and the bound β-endorphin or fragments thereof containing the (6-15) residue sequence; measuring the amount of labeled β-endorphin or fragments thereof containing the (6-15) reside sequence from either the free or bound β-endorphin or fragments thereof containing the (6-15) residue sequence and determining the concentration of β-endorphin of fragments thereof containing the (6-15) residue sequence in the test sample by reference to a standard curve.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-06-19 1981-12-19 1982-06-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-06-19 1985-12-19 1986-06-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-06-19 1989-12-19 1990-06-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag